⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11681881 | 0.83 | — | — | |
| SCHEMBL29852203 | 0.80 | — | — | |
| SCHEMBL9473498 | 0.79 | TSHR (0.35) | — | |
| SCHEMBL30140506 | 0.78 | ALDH1A1 (0.36) | — | |
| SCHEMBL201361 | 0.72 | — | — | |
| SCHEMBL8406935 | 0.71 | — | — | |
| SCHEMBL27785624 | 0.71 | — | — | |
| SCHEMBL594532 | 0.69 | ALDH1A1 (0.35) | — | |
| SCHEMBL29087063 | 0.67 | — | — | |
| SCHEMBL4383428 | 0.67 | MEN1 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230082611-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS | CIDARA THERAPEUTICS, INC. | 2023-03-16 | — | — | US | disclosed |
| EP-4028392-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS | CIDARA THERAPEUTICS, INC. (US) | 2022-07-20 | — | — | EP | disclosed |
| CN-114728937-A | Compositions and methods for treating respiratory syncytial virus | 奇达拉治疗公司 | 2022-07-08 | — | — | CN | disclosed |
| CN-114390929-A | Compositions and methods for treating respiratory syncytial virus | 奇达拉治疗公司 | 2022-04-22 | — | — | CN | disclosed |
| EP-3982994-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS | CIDARA THERAPEUTICS, INC. (US) | 2022-04-20 | — | — | EP | disclosed |
| WO-2021050612-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS | CIDARA THERAPEUTICS, INC. (US) | 2021-03-18 | — | — | WO | disclosed |
| WO-2020252396-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS | CIDARA THERAPEUTICS, INC. (US) | 2020-12-17 | — | — | WO | disclosed |
| US-6858679-B2 | Compositions providing improved functionalization of terminal anions and processes for improved functionalization of terminal anions | FMC CORPORATION (US) | 2005-02-22 | — | — | US | disclosed |
| US-6812295-B2 | ELECTROPHILES FOR TELECHELIC POLYMERS | FMC CORPORATION | 2004-11-02 | — | — | US | disclosed |
| US-20040176545-A1 | FUNCTIONALIZED INITIATORS FOR ANIONIC POLYMERIZATION, PROTECTED FUNCTIONALIZED POLYMERS, DEPROTECTED ANALOGUES THEREOF, AND METHODS OF MAKING THE SAME | SCHWINDEMAN JAMES ANTHONY (US) | 2004-09-09 | — | — | US | disclosed |
| EP-1363953-A2 | FUNCTIONALIZED INITIATORS FOR ANIONIC POLYMERIZATION, PROTECTED FUNTIONALIZED POLYMERS, DEPROTECTED ANALOGUES THEREOF, AND METHODS OF MAKING THE SAME | FMC CORPORATION (US) | 2003-11-26 | — | — | EP | disclosed |
| EP-1028982-B1 | COMPOSITIONS PROVIDING IMPROVED FUNCTIONALIZATION OF TERMINAL ANIONS AND PROCESSES FOR IMPROVED FUNCTIONALIZATION OF TERMINAL ANIONS | FMC CORP (US) | 2003-10-29 | — | — | EP | disclosed |
| US-20030153693-A1 | Compositions providing improved functionalization of terminal anions and processes for improved functionalization of terminal anions | QUIRK RODERIC PAUL (US) | 2003-08-14 | — | — | US | disclosed |
| US-6605564-B1 | Anionic polymerization initiators and salt additives selected from sodium chloride, sodium iodide, potassium chloride, potassium t-butoxide, for increasing the efficiency of reactions between living polymer anions and electrophiles | FMC CORPORATION | 2003-08-12 | — | — | US | disclosed |
| US-6545103-B2 | Living polymers | FMC CORPORATION | 2003-04-08 | — | — | US | disclosed |
| US-20030023020-A1 | Functionalized initiators for anionic polymerization, protected functionalized polymers, deprotected analogues thereof, and methods of making the same | FMC CORPORATION | 2003-01-30 | — | — | US | disclosed |
| WO-2002060958-A2 | FUNCTIONALIZED INITIATORS FOR ANIONIC POLYMERIZATION, PROTECTED FUNTIONALIZED POLYMERS, DEPROTECTED ANALOGUES THEREOF, AND METHODS OF MAKING THE SAME | FMC CORPORATION (US) | 2002-08-08 | — | — | WO | disclosed |
| US-20020010082-A1 | Compositions providing improved functionalization of terminal anions and processes for improved functionalization of terminal anions | FMC CORPORATION | 2002-01-24 | — | — | US | disclosed |
| EP-1028982-A1 | COMPOSITIONS PROVIDING IMPROVED FUNCTIONALIZATION OF TERMINAL ANIONS AND PROCESSES FOR IMPROVED FUNCTIONALIZATION OF TERMINAL ANIONS | FMC CORPORATION (US) | 2000-08-23 | — | — | EP | disclosed |
| WO-1999025740-A1 | COMPOSITIONS PROVIDING IMPROVED FUNCTIONALIZATION OF TERMINAL ANIONS AND PROCESSES FOR IMPROVED FUNCTIONALIZATION OF TERMINAL ANIONS | FMC CORPORATION (US) | 1999-05-27 | — | — | WO | disclosed |